{'fraction_non_alphanumeric': 0.028064992614475627, 'fraction_numerical': 0.019202363367799114, 'mean_word_length': 4.794871794871795, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Cyclosporine A and thiotepa in prevention of postoperative recurrence of pterygium].

PURPOSE
To evaluate the efficiency of Cyclosporine A and Thiotepa to decrease the postoperative recurrence rate of pterygium.


METHODS
50 patients (50 eyes) with pterygium were treated with bare sclera resection and divided into two groups. One group used 1% cyclosporine A eye drops, the other group used 0.05% thiotepa eye drops.


RESULTS
The average follow-up time is 10 months. The recurrence rate of cyclosporine group and thiotepa group is 5% and 10%.


CONCLUSION
Cyclosporine A and Thiotepa can inhibit the hyperplasia of pterygium, and decrease the postoperative recurrence rate.